Literature DB >> 9454693

Antigenic sites of coxsackievirus A9.

T Pulli1, H Lankinen, M Roivainen, T Hyypiä.   

Abstract

Antigenic analysis of coxsackievirus A9 (CAV9) was carried out by using a peptide scanning method. Immunogenic regions in the capsid proteins VP1, VP2, and VP3 were recognized by antibodies in the sera of virus-immunized rabbits. The peptide sequences were scanned using a 12-amino-acid window and three-residue shift. Three immunogenic regions, located in the N- and C-terminal parts of VP1 and in the N-terminus of VP3, were identified. Trypsin treatment of the virus, known to cleave off the C-terminus of VP1 containing a functional RGD motif, completely abolished the reactivity against this region but did not have any other significant effect on antigenicity. In further studies, it was found that the RGD motif itself was poorly immunogenic whereas antibody-binding sites were located at both sides of the motif. New antigenic sites emerged after heat treatment of CAV9 at 56 or 100 degrees C prior to immunization; in particular, loop structures between beta strands in VP2 exhibited increased immunogenicity. New antigenic sites in VP1 and VP3 also appeared after the treatments. In spite of the markedly altered reactivity in peptide scanning, the virus treated at 56 degrees C elicited high titers of neutralizing antibodies. To reveal cross-reactive antigenic sites, antisera raised against coxsackievirus B3 and echovirus 11 were also tested. The cross-reactive antigenic sites were located mainly in the N-terminal parts of VP1 and VP3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454693     DOI: 10.1006/viro.1997.8908

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Structure of the Fab-labeled "breathing" state of native poliovirus.

Authors:  Jun Lin; Lily Y Lee; Merja Roivainen; David J Filman; James M Hogle; David M Belnap
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

2.  Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003.

Authors:  Masae Iwai; Hiromu Yoshida; Mayumi Obara; Eiji Horimoto; Kazuya Nakamura; Takenori Takizawa; Takeshi Kurata; Mineyuki Mizuguchi; Tohru Daikoku; Kimiyasu Shiraki
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

3.  Analysis of the genetic and the corresponding antigenic variability of the VP1 3' end of ECHO virus type 11 and ECHO virus type 30.

Authors:  Lamjed Bouslama; Jawhar Gharbi; Mahjoub Aouni
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

Review 4.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

Review 5.  Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants.

Authors:  Laudi Olijve; Lance Jennings; Tony Walls
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

6.  Entry of human parechovirus 1.

Authors:  P Joki-Korpela; V Marjomäki; C Krogerus; J Heino; T Hyypiä
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Human Memory B Cells Producing Potent Cross-Neutralizing Antibodies against Human Parechovirus: Implications for Prevalence, Treatment, and Diagnosis.

Authors:  B M Westerhuis; K S M Benschop; G Koen; Y B Claassen; K Wagner; A Q Bakker; K C Wolthers; T Beaumont
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

8.  Internalization of coxsackievirus A9 is mediated by {beta}2-microglobulin, dynamin, and Arf6 but not by caveolin-1 or clathrin.

Authors:  Outi Heikkilä; Petri Susi; Tuire Tevaluoto; Heidi Härmä; Varpu Marjomäki; Timo Hyypiä; Saija Kiljunen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

9.  Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization.

Authors:  Umesh Katpally; Tong-Ming Fu; Daniel C Freed; Danilo R Casimiro; Thomas J Smith
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

10.  Diagnostic potential of parechovirus capsid proteins.

Authors:  Annu Alho; Jane Marttila; Jorma Ilonen; Timo Hyypiä
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.